Bosh sahifa600812 ā¢ SHA
add
North China Pharmaceutical Co Ltd
Yopilish kursi
5,03Ā Ā„
Kunlik diapazon
4,90Ā Ā„ - 5,28Ā Ā„
Yillik diapazon
3,83Ā Ā„ - 6,22Ā Ā„
OŹ»rtacha hajm
17,38Ā mln
Narx/foyda
112,40
Dividend daromadliligi
0,19%
Asosiy maydon
SHA
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
(CNY) | sen, 2024info | Y/Y qiyosi |
---|---|---|
Daromad | 2,33Ā mlrd | -15,04% |
Joriy xarajat | 539,22Ā mln | -19,20% |
Sof foyda | 30,48Ā mln | 2Ā 035,14% |
Sof foyda marjasi | 1,31 | 2Ā 520,00% |
Har bir ulushga tushum | ā | ā |
EBITDA | 362,65Ā mln | 6,65% |
Amaldagi soliq stavkasi | 32,92% | ā |
Balans
Jami aktivlari
Jami passivlari
(CNY) | sen, 2024info | Y/Y qiyosi |
---|---|---|
Naqd pul va qisqa investitsiyalar | 1,72Ā mlrd | 15,99% |
Jami aktivlari | 21,71Ā mlrd | 0,92% |
Jami passivlari | 15,10Ā mlrd | -0,95% |
Umumiy kapital | 6,61Ā mlrd | ā |
Tarqatilgan aksiyalar | 1,72Ā mlrd | ā |
Narxi/balansdagi bahosi | 1,61 | ā |
Aktivlardan daromad | 2,06% | ā |
Kapitaldan daromad | 2,47% | ā |
Pul aylanmasi
Naqd pulning sof oŹ»zgarishi
(CNY) | sen, 2024info | Y/Y qiyosi |
---|---|---|
Sof foyda | 30,48Ā mln | 2Ā 035,14% |
Operatsiyalardan naqd pul | 175,21Ā mln | -46,70% |
Sarmoyadan naqd pul | -153,19Ā mln | 10,80% |
Moliyadan naqd pul | -76,80Ā mln | 67,74% |
Naqd pulning sof oŹ»zgarishi | -55,38Ā mln | 30,27% |
BoŹ»sh pul | -660,87Ā mln | -459,21% |
Haqida
North China Pharmaceutical Group Corp., is a pharmaceutical manufacturer in China. NCPC was one of the key construction projects during China's First Five-Year Plan. After five years of construction since the foundation date in June 1953, the first successful pharmaceutical production, started in June 1958. Being one of the antibiotic producers both in technology and production scale at that time, NCPC created a history of commercial production of antibiotics in China. It has 45 years of development experience. NCPC has been taking the lead in the Chinese pharmaceutical industry in key economic indexes, ranked as one of the Top500 Enterprises and the best profit-makers in China. By the end of 2002, the total assets of the company were valued at US$2 billion, with 18,500 employees. In 2002, NCPC claimed a domestic sales revenue of US$700 million and export sales of US$100 million. Wikipedia
Tashkil etilgan
20-dek, 1992
Xodimlar soni
10Ā 159